These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33875812)

  • 1. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis.
    Young JA; Pallas CR; Knovich MA
    Bone Marrow Transplant; 2021 Aug; 56(8):1805-1817. PubMed ID: 33875812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand.
    Lazana I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
    Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
    J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compassionate Use Narsoplimab for Severe Refractory Transplantation-Associated Thrombotic Microangiopathy in Children.
    Schoettler ML; Patel S; Bryson E; Deeb L; Watkins B; Qayed M; Chandrakasan S; Fitch T; Silvis K; Jones J; Chonat S; Williams KM
    Transplant Cell Ther; 2024 Mar; 30(3):336.e1-336.e8. PubMed ID: 38145741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.
    Jodele S; Laskin BL; Dandoy CE; Myers KC; El-Bietar J; Davies SM; Goebel J; Dixon BP
    Blood Rev; 2015 May; 29(3):191-204. PubMed ID: 25483393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in Diagnosis and Treatment of Transplant-Associated Thrombotic Microangiopathy --Review].
    Geng YK; Wang T; Song ZQ; Yang JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):602-606. PubMed ID: 37096542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Dandoy CE; Myers KC; El-Bietar J; Nelson A; Wallace G; Laskin BL
    Transfus Apher Sci; 2016 Apr; 54(2):181-90. PubMed ID: 27156964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
    Jodele S; Dandoy CE; Sabulski A; Koo J; Lane A; Myers KC; Wallace G; Chima RS; Teusink-Cross A; Hirsch R; Ryan TD; Benoit S; Davies SM
    Transplant Cell Ther; 2022 Jul; 28(7):392.e1-392.e9. PubMed ID: 35490975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients.
    Jodele S; Sabulski A
    Expert Rev Hematol; 2021 Aug; 14(8):751-763. PubMed ID: 34301169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reeling in complement in transplant-associated thrombotic microangiopathy: You're going to need a bigger boat.
    Jodele S; Sabulski A
    Am J Hematol; 2023 May; 98 Suppl 4():S57-S73. PubMed ID: 36746623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
    Jodele S; Dandoy CE; Lane A; Laskin BL; Teusink-Cross A; Myers KC; Wallace G; Nelson A; Bleesing J; Chima RS; Hirsch R; Ryan TD; Benoit S; Mizuno K; Warren M; Davies SM
    Blood; 2020 Mar; 135(13):1049-1057. PubMed ID: 31932840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative complement pathway activation product Ba as a marker for transplant-associated thrombotic microangiopathy.
    Sartain S; Shubert S; Wu MF; Wang T; Martinez C
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28070. PubMed ID: 31774252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of transplant-associated thrombotic microangiopathy].
    Ikezoe T
    Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.
    Elhadad S; Redmond D; Huang J; Tan A; Laurence J
    Clin Exp Immunol; 2023 Jul; 213(2):252-264. PubMed ID: 37191586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong.
    Chan WYK; Ma ALT; Chan EYH; Kan ANC; Ng WF; Lee PPW; Cheuk DKL; Chiang AKS; Leung W; Chan GCF
    Pediatr Transplant; 2022 Nov; 26(7):e14366. PubMed ID: 35860972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
    Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.